Shanghai Junshi Biosciences Co., Ltd. (SHJBF)
USD 1.97
(51.54%)
USD 1.97
(51.54%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -2.28 Billion CNY | 4.38% |
| 2022 | -2.38 Billion CNY | -232.06% |
| 2021 | -718.55 Million CNY | 56.86% |
| 2020 | -1.66 Billion CNY | -123.9% |
| 2019 | -743.92 Million CNY | -3.84% |
| 2018 | -716.41 Million CNY | -123.29% |
| 2017 | -320.84 Million CNY | -143.12% |
| 2016 | -131.96 Million CNY | -127.65% |
| 2015 | -57.97 Million CNY | -129.55% |
| 2014 | -25.25 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -362.66 Million CNY | -27.51% |
| 2024 Q1 | -39.33 Million USD | 66.91% |
| 2024 Q3 | -39.43 Million USD | 23.76% |
| 2023 Q2 | -64.67 Million USD | 18.43% |
| 2023 Q4 | -121.32 Million USD | 70.44% |
| 2023 Q3 | -410.39 Million CNY | -534.6% |
| 2023 FY | -2.28 Billion CNY | 4.38% |
| 2023 Q1 | -79.28 Million USD | 89.98% |
| 2022 Q2 | -78 Million USD | -25.4% |
| 2022 Q4 | -791.33 Million CNY | -15.79% |
| 2022 FY | -2.38 Billion CNY | -232.06% |
| 2022 Q3 | -683.4 Million CNY | -776.14% |
| 2022 Q1 | -62.2 Million USD | -21.09% |
| 2021 Q1 | 58.1 Million USD | 0.0% |
| 2021 FY | -718.55 Million CNY | 56.86% |
| 2021 Q4 | -51.36 Million USD | 17.12% |
| 2021 Q3 | -61.97 Million USD | -8.77% |
| 2021 Q2 | -56.98 Million USD | -198.06% |
| 2020 FY | -1.66 Billion CNY | -123.9% |
| 2019 FY | -743.92 Million CNY | -3.84% |
| 2018 FY | -716.41 Million CNY | -123.29% |
| 2017 FY | -320.84 Million CNY | -143.12% |
| 2016 FY | -131.96 Million CNY | -127.65% |
| 2015 FY | -57.97 Million CNY | -129.55% |
| 2014 FY | -25.25 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | -3.17 Million USD | -71842.931% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -61395.421% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -95731.524% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 4406.657% |
| GB Sciences, Inc. | -1.36 Million USD | -167459.855% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -75297.297% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -1000055.177% |
| Skye Bioscience, Inc. | -37.64 Million USD | -5960.93% |
| Zenith Capital Corp. | -10.59 Million USD | -21432.88% |
| Agentix Corp. | -1.37 Million USD | -165931.563% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -32574.747% |
| Biomind Labs Inc. | -1.21 Million USD | -187793.297% |
| ContraFect Corporation | -65.15 Million USD | -3401.948% |
| CSL Limited | 2.64 Billion USD | 186.36% |
| CytoDyn Inc. | -49.84 Million USD | -4477.805% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -116951.439% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -360684.115% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | -3544.825% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -549055.072% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -125227.597% |
| Regen BioPharma, Inc. | 1.02 Million USD | 223021.951% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 3603.027% |
| SQZ Biotechnologies Company | -79.46 Million USD | -2771.267% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -105052.976% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | -2943.667% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -78783.582% |
| Mesoblast Limited | -87.95 Million USD | -2494.052% |
| Marizyme, Inc. | -65.34 Million USD | -3391.556% |
| Genus plc | 7.9 Million USD | 28981.316% |
| Pharming Group N.V. | -10.54 Million USD | -21530.868% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -25698.553% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -131980.083% |
| IMV Inc. | -36.48 Million USD | -6153.476% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -28209.107% |
| MultiCell Technologies, Inc. | -380.07 USD | -600316683.75% |
| ONE Bio Corp. | 8.67 Million USD | 26396.255% |
| RVL Pharmaceuticals plc | -51.69 Million USD | -4313.882% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -61020.386% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -73458.822% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -28770.013% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -15235102.991% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -14275.656% |
| Alpha Cognition Inc. | -13.77 Million USD | -16466.44% |
| Enzolytics Inc. | -2.17 Million USD | -104713.968% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | -673.293% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 2328287.755% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 33049.571% |
| Genscript Biotech Corporation | -95.47 Million USD | -2289.711% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -34595.643% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -834430.837% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -54932.784% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -3774885.064% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -113690.182% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -20848.203% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -46596.573% |
| Adynxx, Inc. | - USD | Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Accustem Sciences Inc. | -3.74 Million USD | -60801.464% |
| Helix BioMedix, Inc. | -1.05 Million USD | -215951.217% |
| EV Biologics, Inc. | -1.26 Million USD | -179961.777% |
| Q BioMed Inc. | -2.05 Million USD | -111085.214% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -59644.017% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | -3720.191% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| BioStem Technologies, Inc. | -8.48 Million USD | -26796.479% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -39121.674% |
| HST Global, Inc. | -146.21 Thousand USD | -1560411.593% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -170753.006% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -129924.032% |
| Halberd Corporation | -79.67 Thousand USD | -2863527.692% |
| Resverlogix Corp. | -3.61 Million USD | -63102.881% |
| Cell Source, Inc. | -5.32 Million USD | -42777.901% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -57328.342% |
| GeneThera, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | -6.41 Million USD | -35474.512% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -9816714.388% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | -4.76 Million USD | -47740.942% |
| Kadimastem Ltd | -3.3 Million USD | -68885.468% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -51258.605% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -516842.513% |
| LadRx Corporation | 400.44 Thousand USD | 569874.974% |
| Regen BioPharma, Inc. | 1.02 Million USD | 223021.951% |
| Affymax, Inc. | -14.42 Million USD | -15718.247% |
| Itoco Inc. | -1.86 Million USD | -121977.587% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -136606.052% |
| Mobile Lads Corp. | -2.26 Million USD | -100709.971% |
| International Stem Cell Corporation | -131 Thousand USD | -1741597.71% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| Bioxytran, Inc. | -4.28 Million USD | -53208.947% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -2886825.715% |
| Qrons Inc. | -789.34 Thousand USD | -288952.09% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -242231.782% |
| SYBLEU INC | -180.3 Thousand USD | -1265331.715% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -109189.825% |
| Rebus Holdings, Inc. | -1.02 Million USD | -223588.627% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -141375.268% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -4203953.656% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -90073.963% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | -4646.264% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -107829.234% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -292083.632% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -71920.96% |
| Neutra Corp. | -233.46 Thousand USD | -977187.388% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -11144.512% |
| PureTech Health plc | -65.69 Million USD | -3372.95% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -10628.705% |
| IXICO plc | -1.17 Million USD | -193586.248% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -22884.023% |
| Gelesis Holdings, Inc. | -57.12 Million USD | -3893.88% |
| CSL Limited | 2.64 Billion USD | 186.36% |
| Cellectis S.A. | -103.17 Million USD | -2111.436% |